Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Real-world treatments and outcomes of resected biliary tract cancers in British Columbia, Canada.
Authors
Mélina Boutin
Centre Intégré de Cancérologie de la Montérégie, Hôpital Charles-Le Moyne, Université de Sherbrooke, Greenfield Park, QC, Canada;
Mélina Boutin , Maria Safro , Jenny Yang , Helia Jafari , Janine Marie Davies , Sharlene Gill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 505)
DOI
10.1200/JCO.2023.41.4_suppl.505
Abstract #
505
Poster Bd #
A15
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Role of adjuvant therapy in resected gallbladder cancer.
First Author: Mohamed Abdelrahim Muddathir Hassan
Poster
2016 Gastrointestinal Cancers Symposium
An institutional analysis of gemcitabine and capecitabine for advanced biliary cancer.
First Author: Shipra Gandhi
Poster
2024 ASCO Genitourinary Cancers Symposium
Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC).
First Author: Sergio Bracarda
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Paclitaxel protein bound (A) plus gemcitabine (G) plus cisplatin (C) and hydroxychloroquine (HCQ) neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC).
First Author: Erkut Hasan Borazanci